| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| CSB119A |
Human anti-Basigin / CD147 (Meplazumab) mAb |
100 µg |
$475.00
|
 |
BUY
|
| CSB119B |
Human anti-Basigin / CD147 (Meplazumab) mAb |
1.0 mg |
$1,395.00
|
|
BUY
|
| CSB111B |
Human anti-ERBB2 / HER2 (Trastuzumab emtansine) mAb |
1.0 mg |
$1,335.00
|
|
BUY
|
| CSB111A |
Human anti-ERBB2 / HER2 (Trastuzumab emtansine) mAb |
100 µg |
$455.00
|
|
BUY
|
| CSB113B |
Human anti-IL-6 Receptor (Sarilumab) mAb |
1.0 mg |
$1,375.00
|
|
BUY
|
| CSB113A |
Human anti-IL-6 Receptor (Sarilumab) mAb |
100 µg |
$470.00
|
|
BUY
|
| CSB120A |
Human anti-IL-6 Receptor (Tocilizumab) mAb |
100 µg |
$470.00
|
|
BUY
|
| CSB120B |
Human anti-IL-6 Receptor (Tocilizumab) mAb |
1.0 mg |
$1,375.00
|
|
BUY
|
| CPC539A |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC539B |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC539C |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC541C |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC541A |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC541B |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CMA006A |
Human anti-TNF alpha (Clone D2E7) Adalimumab |
200 μg |
$690.00
|
|
BUY
|
| CMA006B |
Human anti-TNF alpha (Clone D2E7) Adalimumab |
1.0 mg |
$2,900.00
|
|
BUY
|
| CSB104A |
Human anti-TNF alpha (Clone D2E7, Adalimumab) mAb |
100 µg |
$500.00
|
|
BUY
|
| CSB104B |
Human anti-TNF alpha (Clone D2E7, Adalimumab) mAb |
1.0 mg |
$1,480.00
|
|
BUY
|
| VVV02903A |
InVivoMAb Anti-HCMV/HHV5 gB Neutralizing Antibody(1G2) |
100 µg |
$475.00
|
|
BUY
|
| VVV02903B |
InVivoMAb Anti-HCMV/HHV5 gB Neutralizing Antibody(1G2) |
1.0 mg |
$1,715.00
|
|
BUY
|
| VVV02901B |
InVivoMAb Anti-HCMV/HHV5 gB Neutralizing Antibody(SM5-1) |
1.0 mg |
$1,670.00
|
|
BUY
|
| VVV02901A |
InVivoMAb Anti-HCMV/HHV5 gB Neutralizing Antibody(SM5-1) |
100 µg |
$475.00
|
|
BUY
|
| VHB63001A |
InVivoMAb Anti-Human GDF11/BMP11 (Iv0062) |
100 µg |
$475.00
|
|
BUY
|
| VHB63001B |
InVivoMAb Anti-Human GDF11/BMP11 (Iv0062) |
1 mg |
$1,715.00
|
|
BUY
|
| VHH28801B |
InVivoMAb Anti-Human IL17A (Iv0029) |
1 mg |
$1,715.00
|
|
BUY
|
| VHH28801A |
InVivoMAb Anti-Human IL17A (Iv0029) |
100 µg |
$475.00
|
|
BUY
|
| VVV00311A |
InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0221) |
100 µg |
$475.00
|
|
BUY
|
| VVV00311B |
InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0221) |
1 mg |
$1,715.00
|
|
BUY
|
| VVV00312A |
InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0222) |
100 µg |
$475.00
|
|
BUY
|
| VVV00312B |
InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0222) |
1 mg |
$1,715.00
|
|
BUY
|
| VVV00315B |
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing (Iv0262) |
1.0 mg |
$1,715.00
|
|
BUY
|
| VVV00315A |
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing (Iv0262) |
100 µg |
$475.00
|
|
BUY
|
| VVV00316B |
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing (Iv0263) |
100 µg |
$1,715.00
|
|
BUY
|
| VVV00316A |
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing (Iv0263) |
100 µg |
$475.00
|
|
BUY
|
| VVV00313A |
InVivoMAb Anti-SARS-CoV-2 RBD Neutralizing (C121) |
100 µg |
$475.00
|
|
BUY
|
| VVV00313B |
InVivoMAb Anti-SARS-CoV-2 RBD Neutralizing (C121) |
1.0 mg |
$1,715.00
|
|
BUY
|
| VVV00314B |
InVivoMAb Anti-SARS-CoV-2 RBD Neutralizing (C135) |
1.0 mg |
$1,715.00
|
|
BUY
|
| VVV00314A |
InVivoMAb Anti-SARS-CoV-2 RBD Neutralizing (C135) |
100 µg |
$475.00
|
|
BUY
|
| DHF68801A |
Research Grade Anti-Human CD156b/ADAM17 (MEDI3622) |
100 ug |
$475.00
|
|
BUY
|
| DHF68801B |
Research Grade Anti-Human CD156b/ADAM17 (MEDI3622) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHB48102A |
Research Grade Anti-Human DKK1 (BHQ880) mAb |
100 µg |
$475.00
|
|
BUY
|
| DHF71402B |
Research Grade Anti-Human DLK1 (ADCT-701) mAb |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHF71402A |
Research Grade Anti-Human DLK1 (ADCT-701) mAb |
100 ug |
$475.00
|
|
BUY
|
| DHJ05001A |
Research Grade Anti-Human IL31 (BMS-981164) |
100 ug |
$475.00
|
|
BUY
|
| DHJ05001B |
Research Grade Anti-Human IL31 (BMS-981164) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHB25301A |
Research Grade Anti-Human LRP6 (GSK3178022) |
100 µg |
$475.00
|
|
BUY
|
| DHB25301B |
Research Grade Anti-Human LRP6 (GSK3178022) |
1 MG |
$1,715.00
|
|
BUY
|
| DHH86501A |
Research Grade Anti-Human SEZ6 (ABBV-011) mAb |
100 ug |
$475.00
|
|
BUY
|
| DHH86501B |
Research Grade Anti-Human SEZ6 (ABBV-011) mAb |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHK13704B |
Research Grade Anti-Human SIGLEC15/CD33L3 (DS1501) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHK13704A |
Research Grade Anti-Human SIGLEC15/CD33L3 (DS1501) mAb |
100 µg |
$420.00
|
|
BUY
|
| DHK23201A |
Research Grade Anti-Human TNFRSF25 (PTX-35) mAb |
100 µg |
$475.00
|
|
BUY
|
| DHK23201B |
Research Grade Anti-Human TNFRSF25 (PTX-35) mAb |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV00317A |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
100 µg |
$420.00
|
|
BUY
|
| DVV00317B |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00317B-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
1.0 mg |
$2,310.00
|
|
BUY
|
| DVV00317X-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
0.5 mg |
$1,485.00
|
|
BUY
|
| DHJ64002B |
Research Grade Azintuxizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ64002A |
Research Grade Azintuxizumab |
100 ug |
$380.00
|
|
BUY
|
| DHD47901B |
Research Grade Bemarituzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD47901A |
Research Grade Bemarituzumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02210A |
Research Grade Budigalimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02210B |
Research Grade Budigalimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD17401A |
Research Grade Citatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD17401B |
Research Grade Citatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC09603B |
Research Grade Disitamab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC09603A |
Research Grade Disitamab |
100 ug |
$380.00
|
|
BUY
|
| DVV00306B |
Research Grade Etesevimab |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV00306A |
Research Grade Etesevimab |
100 ug |
$475.00
|
|
BUY
|
| DHH02233A |
Research Grade Peresolimab |
100 µg |
$420.00
|
|
BUY
|
| DHH02233B |
Research Grade Peresolimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHH02216A |
Research Grade Pidilizumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02216B |
Research Grade Pidilizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ48301B |
Research Grade Ponsegromab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHJ48301A |
Research Grade Ponsegromab |
100 ug |
$420.00
|
|
BUY
|
| DHH02234A |
Research Grade Rosnilimab |
100 µg |
$420.00
|
|
BUY
|
| DHH02234B |
Research Grade Rosnilimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHC34203A |
Research Grade Telisotuzumab |
100 ug |
$420.00
|
|
BUY
|
| DHC34203B |
Research Grade Telisotuzumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHC34299A |
Research Grade Telisotuzumab vedotin (ADC) |
1.0 mg |
$2,915.00
|
|
BUY
|
| DHC34299B |
Research Grade Telisotuzumab vedotin (ADC) |
5.0 mg |
$6,325.00
|
|
BUY
|
| DHC09605B |
Research Grade Timigutuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC09605A |
Research Grade Timigutuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHA30101A |
Research Grade Vesencumab |
100 ug |
$380.00
|
|
BUY
|
| DHA30101B |
Research Grade Vesencumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD52901B |
Research Grade Vofatamab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD52901A |
Research Grade Vofatamab |
100 ug |
$420.00
|
|
BUY
|
| DHJ92101B |
Research Grade Vopratelimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ92101A |
Research Grade Vopratelimab |
100 ug |
$380.00
|
|
BUY
|
| DHE16605A |
Research Grade Vulinacimab |
100 ug |
$380.00
|
|
BUY
|
| DHE16605B |
Research Grade Vulinacimab |
1.0 ug |
$1,380.00
|
|
BUY
|
| DHC09609A |
Research Grade Zenocutuzumab |
100 ug |
$560.00
|
|
BUY
|
| DHC09609B |
Research Grade Zenocutuzumab |
1.0 mg |
$2,030.00
|
|
BUY
|
